Condition
Primary Solid Tumors
Total Trials
2
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by 131itm601 Chlorotoxin
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT06466070Enrolling By InvitationPrimary
Robotic Surgery in Pulmonary Metastasectomy
NCT00379132Phase 1Completed
131-I-TM-601 Study in Adults With Solid Tumors
Showing all 2 trials
Research Network
Common Treatments
- 131itm601 Chlorotoxin1
Active Sponsors
- Istituto Europeo di Oncologia1
- Istituto Clinico Humanitas1
- TransMolecular1
- Scientific Institute San Raffaele1
Top Investigators
Mary Crowley Medical Research Center
Lacks Cancer Center at St. Mary's Health Care
Northwestern University
University of Chicago
Tufts Medical Center
Related Conditions
- Melanoma1
- Pancreatic Cancer1
- Nonsmall Cell Lung Cancer1
- Prostate Adenocarcinoma1
- Glioma1